Tenet Healthcare Corp
THC- Exchange
- NYSE
- Industry
- Services-General Medical & Surgical Hospitals, NEC
- SEC CIK
- 0000070318
In the last 90 days, Tenet Healthcare Corp insiders filed 0 open-market purchases and 7 sales; 688 institutions reported holding it in 13F filings for Q2 2026, worth $15.0B in total; Harris Associates (Oakmark) is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 30, 2026, 1:13 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 2, 2026 | Feb 12, 2025 | Feb 1, 2024 | Jan 19, 2023 | Jan 11, 2022 |
| Revenue | $21.3B | $20.7B | $20.5B | $19.2B | $19.5B |
| Operating income | $3.51B | $5.96B | $2.51B | $2.33B | $2.87B |
| Interest expense | – | – | $901.0M | $890.0M | $923.0M |
| Income tax | $433.0M | $1.18B | $306.0M | $344.0M | $411.0M |
| Net income | $2.37B | $4.06B | $1.31B | $1.00B | $1.48B |
| EPS, basic | $15.61 | $33.02 | $6.01 | $3.84 | $8.55 |
| EPS, diluted | $15.49 | $32.70 | $5.71 | $3.79 | $8.42 |
| Weighted shares, basic | 90.2M | 96.9M | 101.6M | 106.9M | 106.8M |
| Weighted shares, diluted | 90.8M | 97.9M | 104.8M | 110.5M | 108.6M |
| Margins and growth | |||||
| Operating margin | 16.5% | 28.8% | 12.2% | 12.2% | 14.7% |
| Net margin | 11.1% | 19.7% | 6.4% | 5.2% | 7.6% |
| Revenue growth, year over year | +3.1% | +0.6% | +7.2% | −1.6% | +10.5% |
| Net income growth, year over year | −41.8% | +210.0% | +31.0% | −32.2% | +92.2% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025! | FY2024! | FY2023! | FY2022! | FY2021! |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 2, 2026 | Feb 12, 2025 | Feb 1, 2024 | Jan 19, 2023 | Jan 11, 2022 |
| Cash and equivalents | $2.88B | $3.02B | $1.23B | $858.0M | $2.36B |
| Accounts receivable | $2.56B | $2.54B | $2.91B | $2.94B | $2.77B |
| Inventory | $348.0M | $346.0M | $411.0M | $405.0M | $384.0M |
| Total current assets | $7.85B | $7.68B | $7.17B | $5.98B | $7.08B |
| Goodwill | $11.2B | $10.7B | $10.3B | $10.1B | $9.26B |
| Intangible assets | $1.35B | $1.40B | $1.37B | $1.42B | $1.50B |
| Total assets | $29.7B | $28.9B | $28.3B | $27.2B | $27.6B |
| Accounts payable | $1.36B | $1.29B | $1.41B | $1.50B | $1.30B |
| Total current liabilities | $4.46B | $4.31B | $4.76B | $4.48B | $5.11B |
| Total liabilities | $20.7B | $20.4B | $22.8B | $22.5B | $23.3B |
| Shareholders' equity | $6.02B | $5.82B | $3.12B | $2.46B | $2.05B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 2, 2026 | Feb 12, 2025 | Feb 1, 2024 | Jan 19, 2023 | Jan 11, 2022 |
| Operating cash flow | $3.54B | $2.05B | $2.37B | $1.08B | $1.57B |
| Capital expenditures | $1.01B | $931.0M | $751.0M | $762.0M | $658.0M |
| Free cash flow | $2.53B | $1.12B | $1.62B | $321.0M | $910.0M |
| Depreciation and amortization | $863.0M | $818.0M | $870.0M | $841.0M | $855.0M |
| Stock-based compensation | $104.0M | $67.0M | $66.0M | $56.0M | $56.0M |
| Share buybacks | $1.39B | $672.0M | $200.0M | $250.0M | – |
| Investing cash flow | -$1.27B | $3.43B | -$969.0M | -$808.0M | -$714.0M |
| Financing cash flow | -$2.40B | -$3.69B | -$1.03B | -$1.78B | -$936.0M |
| Net change in cash | -$136.0M | $1.79B | $370.0M | -$1.51B | -$82.0M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.5% | 0.3% | 0.3% | 0.3% | 0.3% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 23, 2026 | 79.6M | −9.4% | SEC |
| Jul 24, 2026 | 80.5M | −8.9% | SEC |
| Apr 22, 2026 | 86.1M | −7.3% | SEC |
| Jan 30, 2026 | 87.0M | −8.6% | SEC |
| Oct 22, 2025 | 87.9M | −7.6% | SEC |
| Jul 18, 2025 | 88.4M | −7.8% | SEC |
| Apr 18, 2025 | 92.9M | −4.9% | SEC |
| Jan 31, 2025 | 95.1M | −4.9% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
- A column marked ! failed an accounting identity (gross profit = revenue − cost of revenue, or assets = liabilities + equity, within 1%). Its numbers are shown as filed.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.